Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$267,414
-$60,096 QoQ
Shares Held
4,641
-14.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,950
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. BMY ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,414 | 4,641 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $327,510 | 5,400 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $310,856 | 5,763 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $383,079 | 8,494 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $388,743 | 8,398 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $621,488 | 10,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $193,944 | 3,429 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $178,865 | 3,457 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $143,569 | 3,457 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $216,703 | 3,996 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $207,702 | 4,048 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $235,700 | 4,061 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $218,261 | 3,413 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $264,902 | 3,822 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $279,669 | 3,887 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $278,957 | 3,924 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $353,353 | 4,589 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $286,569 | 3,924 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $178,321 | 2,860 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $262,773 | 4,441 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $296,747 | 4,441 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $273,984 | 4,340 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $251,469 | 4,054 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $245,983 | 4,080 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $235,141 | 3,999 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $216,159 | 3,878 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||